What is Third Pole Therapeutics?
Third Pole Therapeutics is dedicated to advancing patient care through its development of portable and wearable devices for the delivery of inhaled nitric oxide. The company's core mission is to broaden the availability of these life-saving respiratory therapies to healthcare providers and patients worldwide. Their technological advancements aim to revolutionize the treatment of various respiratory conditions, positioning them as a key player in the medical device and healthcare innovation sector.
How much funding has Third Pole Therapeutics raised?
Third Pole Therapeutics has raised a total of $39.1M across 3 funding rounds:
Unspecified
$13.8M
Debt
$350K
Unspecified
$25M
Unspecified (2015): $13.8M, investors not publicly disclosed
Debt (2020): $350K led by PPP
Unspecified (2022): $25M, investors not publicly disclosed
What's next for Third Pole Therapeutics?
With a substantial enterprise-level funding history, Third Pole Therapeutics is poised for significant expansion and further clinical validation. The recent strategic investment likely fuels the scaling of manufacturing, broader market penetration, and continued research and development for their inhaled nitric oxide delivery systems. Future growth will likely involve strategic partnerships within the healthcare ecosystem and navigating regulatory pathways to ensure widespread adoption of their innovative therapies.
See full Third Pole Therapeutics company page
